EHC Stock Recent News
EHC LATEST HEADLINES
Encompass Health (EHC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
EHC, GLDD and BSAC made it to the Zacks Rank #1 (Strong Buy) growth stocks list on May 15, 2025.
EHC already boasts a massive footprint of 167 hospitals in 38 states and Puerto Rico.
It has been a turbulent start to the year for the healthcare industry, as concerns about major cuts to Medicare and Medicaid coincide with the impact of tariffs on supplies and many other variables. Nonetheless, healthcare stocks have fared well compared to the energy and information technology sectors.
Encompass Health (EHC) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Does Encompass Health (EHC) have what it takes to be a top stock pick for momentum investors? Let's find out.
The Company will award research-funding grants totaling up to $60,000 BIRMINGHAM, Ala. , May 2, 2025 /PRNewswire/ -- Encompass Health is pleased to announce the opening of its request for 2025 research grant applications due Sept.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
BIRMINGHAM, Ala. , May 1, 2025 /PRNewswire/ -- Encompass Health Corporation (NYSE: EHC) today announced that its board of directors has declared a quarterly cash dividend on its common stock of $0.17 per share, payable on July 15, 2025, to holders of record on July 1, 2025.